Skip to main content

Evaluation of Preoperative Serum CEA and IAP Levels in the Patients with Colorectal Cancer

  • Conference paper
Recent Advances in Management of Digestive Cancers

Abstract

The usefulness of the preoerative measurement of serum CEA and IAP level as prognostic factors in colorectal cancer patients was investigated. The cases were divided into negative or positive groups acording to cut off points of CEA of 5ng/ml, IAP of 500μg/ml orIAP of 580μg/ml respectivly. In comparison of survival rates in colon cancer, the groups of CEA negative, IAP500 negative or IAP580 negative were all significantly better than those of positive ones respectivly. But in rectal cancer, only the rate of IAP580 negative one was significantly better than that of positive one. To further investigation of above results, according to the general rules for clinical and pathological studies on cancer of colon, rectum and anus in Japan, distributions of cases by histological backgrounds and by these cut off points were analized. Results were those both in colon and rectal cancer, CEA correlated almost all bacgrounds except histological type and lymphnode metastasis. But IAP500 correlated only operative curability in rectal cancer, and also IAP580 corelated only operative culability in both colon and rectal cancer and lymphnode metastasis in colon cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Sakamoto J, Kato K, Tanemura H, Watanabe T, Nagata I, Kishikawa H, Itou y, Teramukai S, Oohashi Y, Ogawa T, Nakasato H (1989) Serum immunosuppresive acidic protein in patients with gastric cancer - statistical resaerch for the cut-off level and evaluation of the effect of biological response modifier PSK -. The 9th Reports of Japan Tumor Makar Association 9:217–220

    Google Scholar 

  2. Gold P, Freedman SO (1965) Demonstration of tumor specific antigen in human colonic carcinoma by immunological tolerance and absorption teqniques. J.Exp.Med. 121:439–462

    Article  PubMed  CAS  Google Scholar 

  3. Currie GA, Basham C (1972) Serum mediated inhibition of the immunological reactions of the patient to his own tumour: A possible role for circulating antigen. Br. J. Cancer 26:427–438

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Tokyo

About this paper

Cite this paper

Umemoto, T., Sugiyama, Y., Saji, S. (1993). Evaluation of Preoperative Serum CEA and IAP Levels in the Patients with Colorectal Cancer. In: Takahashi, T. (eds) Recent Advances in Management of Digestive Cancers. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68252-3_144

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68252-3_144

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68254-7

  • Online ISBN: 978-4-431-68252-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics